Skip to menu Skip to content Skip to footer

2023

Conference Publication

Structural basis of an anti-cancer biological warhead bound to its target CDCP1 for the diagnosis and treatment of epithelial cancers

Kwah, Kayden, Gu, Weixi, Arachchige, Kasun S. A., He, Yaowu, Landsberg, Michael, Kobe, Bostjan and Hooper, John (2023). Structural basis of an anti-cancer biological warhead bound to its target CDCP1 for the diagnosis and treatment of epithelial cancers. XXVI IUCr Congress, Melbourne, VIC Australia, 22-29 August 2023. Hoboken, NJ United States: Wiley-Blackwell. doi: 10.1107/s2053273323084449

Structural basis of an anti-cancer biological warhead bound to its target CDCP1 for the diagnosis and treatment of epithelial cancers

2023

Conference Publication

Development of a CUB domain-containing protein 1 (CDCP1)-targeting antibody-drug conjugate for triple-negative and metastatic breast cancer

Gough, Madeline, Kwah, Kayden, He, Yaowu, Snell, Cameron Edward, Hooper, John D. and Kryza, Thomas (2023). Development of a CUB domain-containing protein 1 (CDCP1)-targeting antibody-drug conjugate for triple-negative and metastatic breast cancer. 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology (ASCO). doi: 10.1200/jco.2023.41.16_suppl.e15012

Development of a CUB domain-containing protein 1 (CDCP1)-targeting antibody-drug conjugate for triple-negative and metastatic breast cancer

2022

Conference Publication

Development of antibody-drug conjugates targeting the CDCP1 receptor for the treatment of Triple negative and metastatic breast cancer

Gough, M., Kwah, K., Khan, T., He, Y., Pyke, C., Ratnayake, G., Snell, C., Hooper, J. and Kryza, T. (2022). Development of antibody-drug conjugates targeting the CDCP1 receptor for the treatment of Triple negative and metastatic breast cancer. 13th European Breast Cancer Conference (EBCC-13), Barcelona, Spain, 16-18 November 2022. Oxford, United Kingdom: Elsevier. doi: 10.1016/s0959-8049(22)01571-4

Development of antibody-drug conjugates targeting the CDCP1 receptor for the treatment of Triple negative and metastatic breast cancer

2019

Conference Publication

"Theranostics": radioimmunodetection and radioimmunotherapy for metastatic colorectal cancer

Cuda, T., Hooper, J., Puttick, S., He, Y., Kryza, T. and Khan, T. (2019). "Theranostics": radioimmunodetection and radioimmunotherapy for metastatic colorectal cancer. Australian and New Zealand Society of Nuclear Medicine (ANZSNM) 49th ASM, Adelaide, Australia, 26-28 April 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia.

"Theranostics": radioimmunodetection and radioimmunotherapy for metastatic colorectal cancer

2019

Conference Publication

Ovarian cancer cell invasiveness regulates their exosomes which induces oncogenic potential and cancer progression in vivo

Alharbi, Mona G., Lai, Andrew, Zuniga, Felipe, Perrin, Lewis, He, Yaowu, Hooper, John D. and Salomon, Carlos (2019). Ovarian cancer cell invasiveness regulates their exosomes which induces oncogenic potential and cancer progression in vivo. 66th Annual Scientific Meeting of the Society for Reproductive Investigation (SRI), Paris, France, March 12-16, 2019. Thousand Oaks, CA, United States: Sage Publications. doi: 10.1177/1933719119834079

Ovarian cancer cell invasiveness regulates their exosomes which induces oncogenic potential and cancer progression in vivo

2018

Conference Publication

Granulocyte Colony Stimulating Factor impacts on osteomacs and bone marrow macrophages - implications for prostate cancer osteoblastic lesion formation

Millard, Susan, Wu, Andy, Kaur, Simran, He, Yaowu, Batoon, Lena, Hooper, John and Pettit, Allison (2018). Granulocyte Colony Stimulating Factor impacts on osteomacs and bone marrow macrophages - implications for prostate cancer osteoblastic lesion formation. Annual Meeting of the American Society for Bone and Mineral Research, Montréal, Quebéc, Canada, Sep 28-Oct 01, 2018. Hoboken, NJ, United States: Wiley-Blackwell Publishing. doi: 10.1002/jbmr.3621

Granulocyte Colony Stimulating Factor impacts on osteomacs and bone marrow macrophages - implications for prostate cancer osteoblastic lesion formation

2016

Conference Publication

MUC13 protects colorectal cancer cells from death by activating the NF-Kb pathway and is a potential therapeutic target

Sheng, Yong H., He, Yaowu, Hasnain, Sumaira Z., Wang, Ran, Tong, Hui, Clarke, Daniel T., Lourie, Rohan, Oancea, Lulia, Wong, Kuanyau, Lumley, John W., Florin, Timothy H., Sutton, Philip, Hooper, John. D., Mcmillan, Nigel A. and Mcguckin, Michael A. (2016). MUC13 protects colorectal cancer cells from death by activating the NF-Kb pathway and is a potential therapeutic target. AACR 107th Annual Meeting on Bioinformatics and Systems Biology, New Orleans, Los Angeles, 16-20 April 2016 . Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2016-3564

MUC13 protects colorectal cancer cells from death by activating the NF-Kb pathway and is a potential therapeutic target

2016

Conference Publication

The role of cancer stem cells in colorectal cancer metastasis

Kemp, M. C., Pummer, J., He, Y., Hooper, J., Reuter, B., Borgovan, T., Zhang, X., Sullivan, R., Maresh, G., Green, H., Del Valle, L., Margolin, D. and Li, L. (2016). The role of cancer stem cells in colorectal cancer metastasis. Southern Regional Meeting of the American Federation for Medical Research (AFMR), New Orleans, LA, United States, Feb 18-20, 2016. London, United Kingdom: BMJ Group. doi: 10.1136/jim-2015-000035.415

The role of cancer stem cells in colorectal cancer metastasis

2016

Conference Publication

Targeting Apoptosis as a Novel Therapy for Myc-Driven Medulloblastoma

Ji, Pengxiang, Genovesi, Laura, He, Yaowu, Hooper, John and Wainwright, Brandon (2016). Targeting Apoptosis as a Novel Therapy for Myc-Driven Medulloblastoma. 17th International Symposium on Pediatric Neuro-Oncology (ISPNO), Liverpool England, 12-15 June 2016. United States: Oxford University Press.

Targeting Apoptosis as a Novel Therapy for Myc-Driven Medulloblastoma

2015

Conference Publication

EGF-induced recycling of the cancer promoting protein CDCP1

Adams, Mark N., Harrington, Brittney S., He, Yaowu, Davies, Claire M., Wallace, Sarah J., Chetty, Naven P., Crandon, Alexander J., Oliveira, Niara B., Shannon, Catherine M., Coward, Jermaine I., Lumley, John W., Perrin, Lewis C., Armes, Jane E. and Hooper, John D. (2015). EGF-induced recycling of the cancer promoting protein CDCP1. 15th International Biennial Congress of the Metastasis Research Society, Heidelberg, Germany, June 28th–July 1st, 2014. Dordrecht, Netherlands: Springer Netherlands. doi: 10.1007/s10585-015-9708-3

EGF-induced recycling of the cancer promoting protein CDCP1

2014

Conference Publication

Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancer

Harrington, B., Davies, C. M., Wallace, S. J., He, Y., Armes, J. E., Perrin, L. C. and Hooper, J. D. (2014). Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancer. London, United Kingdom: B M J Group.

Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancer

2014

Conference Publication

A New Marker of Poor Outcome and Potential Therapeutic Target in Ovarian Clear Cell Carcinoma

Hooper, J., He, Y., Wu, A., Harrington, B., Davies, C., Wallace, S., Gilks, B., Perrin, L. and Armes, J. (2014). A New Marker of Poor Outcome and Potential Therapeutic Target in Ovarian Clear Cell Carcinoma. 15th Biennial Meeting of the International Gynecologic Cancer Society, Melbourne, VIC Australia, 8-11 November 2014. London, United Kingdom: Lippincott Williams and Wilkins. doi: 10.1097/01.IGC.0000457075.08973.89

A New Marker of Poor Outcome and Potential Therapeutic Target in Ovarian Clear Cell Carcinoma

2006

Conference Publication

The downstream targets of hnRNP A2 proteins in squamous cell carcinoma cells

He, Y., Epis, M. R., Rothnagel, J. A., Leedman, P. J. and Smith, R. W. (2006). The downstream targets of hnRNP A2 proteins in squamous cell carcinoma cells. ComBio 2006, Brisbane, Australia, 25-28 Sept, 2006. Kent Town, S.A., Australia: Australian Society for Biochemistry and Molecular Biology.

The downstream targets of hnRNP A2 proteins in squamous cell carcinoma cells

2006

Conference Publication

hnRNPs A2/B1: A different splice for a different life?

He, Y., Epis, M. R., Rothnagel, J. A., Leedman, P. J. and Smith, R. W. (2006). hnRNPs A2/B1: A different splice for a different life?. ComBio 2006, Brisbane, Australia, 25-28 Sept, 2006. Kent Town, S.A., Australia: Australian Society for Biochemistry and Molecular Biology.

hnRNPs A2/B1: A different splice for a different life?

2003

Conference Publication

Cell cycle-dependence of expression of the hnRNP A2/B1 proteins and their roles in carcinogenesis

He, Y. and Smith, R. W. (2003). Cell cycle-dependence of expression of the hnRNP A2/B1 proteins and their roles in carcinogenesis. ComBio 2003, Sydney, 28 Sept - 2 Oct, 2003.

Cell cycle-dependence of expression of the hnRNP A2/B1 proteins and their roles in carcinogenesis

1998

Conference Publication

Treatment of domestic wastewater by an underground capillary seepage system

Sun, Tieheng, He, Yaowu, Ou, Ziqing, Li, Peijun, Chang, Shijun, Qi, Bing, Ma, Xuejun, Qi, Enshan, Zhang, Hairong, Ren, Liping and Yang, Guifeng (1998). Treatment of domestic wastewater by an underground capillary seepage system. International Conference on Ecological Engineering (ICEE 96), Beijing, Peoples Republic of China, 7-11 October 1996. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0925-8574(98)00027-5

Treatment of domestic wastewater by an underground capillary seepage system